miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway

Journal of Hematology & Oncology
Hong LiYuntao Lu

Abstract

Chemoresistance to temozolomide (TMZ) is a major challenge in the treatment of glioblastoma (GBM). We previously found that miR-519a functions as a tumor suppressor in glioma by targeting the signal transducer and activator of transcription 3 (STAT3)-mediated autophagy oncogenic pathway. Here, we investigated the effects of miR-519a on TMZ chemosensitivity and autophagy in GBM cells. Furthermore, the underlying molecular mechanisms and signaling pathways were explored. In the present study, two stable TMZ-resistant GBM cell lines were successfully generated by exposure of parental cells to a gradually increasing TMZ concentration. After transfecting U87-MG/TMZ and U87-MG cells with miR-519a mimic or inhibitor, a series of biochemical assays such as MTT, apoptosis, and colony formation were performed to determine the chemosensitive response to TMZ. The autophagy levels in GBM cells were detected by transmission electron microscopy, LC3B protein immunofluorescence, and Western blotting analysis. Stable knockdown and overexpression of miR-519a in GBM cells were established using lentivirus. A xenograft nude mouse model and in situ brain model were used to examine the in vivo effects of miR-519a. Tumor tissue samples were collected...Continue Reading

References

Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Dec 7, 2007·Cancer Research·Joanne B WeidhaasFrank J Slack
May 29, 2008·Molecular Cancer Research : MCR·Emily C Brantley, Etty N Benveniste
Jan 6, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Atreyi DasguptaSaikh Jaharul Haque
Feb 13, 2009·Molecular Biology of the Cell·Nao HosokawaNoboru Mizushima
Mar 28, 2009·Cell Death and Differentiation·A Eisenberg-LernerA Kimchi
Aug 6, 2009·Annual Review of Genetics·Congcong He, Daniel J Klionsky
Dec 1, 2011·Apoptosis : an International Journal on Programmed Cell Death·Eleonora FranzettiGianluca Tettamanti
Dec 14, 2011·The Journal of Biological Chemistry·Zhenyou ZouKe Zen
May 9, 2012·Journal of Neurochemistry·Caroline HappoldMichael Weller
May 16, 2013·Genome Research·KiYoung LeeBonghee Lee
Jul 10, 2013·Current Drug Targets·Hugo SecaM Helena Vasconcelos
Dec 7, 2013·Journal of Hematology & Oncology·Muhammad FurqanDelong Liu
Dec 30, 2014·Cancer Letters·Alfeu Zanotto-FilhoJosé Cláudio Fonseca Moreira
May 8, 2015·Autophagy·Liangkun YouWeidong Han
Jun 13, 2015·Journal of Hematology & Oncology·Srivatsava NaiduMichela Garofalo
Jul 23, 2015·Journal of Hematology & Oncology·Bin LiShi-Ting Li
Sep 3, 2016·Journal of Hematology & Oncology·Haouraa MostafaE Marion Schneider
Mar 30, 2017·Journal of Hematology & Oncology·Dagny von AhrensAmit Verma

❮ Previous
Next ❯

Citations

Apr 10, 2020·Clinical and Experimental Pharmacology & Physiology·Jiaojiao LuLe Zhao
Aug 8, 2019·International Journal of Molecular Sciences·Larisa RyskalinFrancesco Fornai
Mar 4, 2020·Molecular Cancer·Xinyi ZhangYongguang Tao
Sep 3, 2020·Cell Biology and Toxicology·Yuanming JingZongliang Huang
Apr 1, 2020·Cancer Biomarkers : Section a of Disease Markers·Yitao WangFeng Li
Jan 22, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Shaosong HuangWei Lin
Aug 16, 2019·Investigational New Drugs·Jingkao ChenRongbiao Pi
Nov 5, 2019·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Wenbing ShangguanNan Tian
Jul 28, 2020·Pharmaceuticals·Angel Escamilla-RamírezCristina Trejo-Solís
Oct 24, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Larisa RyskalinFrancesco Fornai
Jan 6, 2021·Journal of Cellular Biochemistry·Li-Bin GaoSong-Lin Shi
Dec 15, 2020·European Journal of Pharmacology·Milad AshrafizadehMasoud Najafi
Sep 22, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fan FengXiujie Wu
Jan 28, 2021·Cancers·Alexander OuAmy B Heimberger
Feb 3, 2021·International Journal of Molecular Sciences·Imran KhanMustafa Aziz Hatiboglu
Nov 17, 2020·Frontiers in Oncology·Jose G Alvarez-MeythalerMatilde E LLeonart
May 14, 2021·Frontiers in Pharmacology·Xiaohui LiangXiaojun Wu
Jul 3, 2021·Cells·Don Carlo Ramos BataraSung-Hak Kim
Jul 3, 2021·International Journal of Molecular Sciences·Maya A DymovaVladimir A Richter
Aug 25, 2021·Cancer Cell International·Zheng BianXiaolu Zhang
Aug 23, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Manendra Singh TomarAshutosh Shrivastava
Oct 4, 2020·Experimental and Molecular Pathology·Omidvar RezaeiSoudeh Ghafouri-Fard

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
PCR
xenograft
transmission electron microscopy
transfection

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms